Cargando…

A SLC16A1 Mutation in an Infant With Ketoacidosis and Neuroimaging Assessment: Expanding the Clinical Spectrum of MCT1 Deficiency

The solute carrier family 16 member 1 (SLC16A1) gene encodes for monocarboxylate transporter 1 (MCT1) that mediates the movement of monocarboxylates, such as lactate and pyruvate across cell membranes. Inactivating recessive homozygous or heterozygous mutations in the SLC16A1 gene were described in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Khawaga, Sara, AlRayahi, Jehan, Khan, Faiyaz, Saraswathi, Saras, Hasnah, Reem, Haris, Basma, Mohammed, Idris, Abdelalim, Essam M., Hussain, Khalid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657212/ https://www.ncbi.nlm.nih.gov/pubmed/31380330 http://dx.doi.org/10.3389/fped.2019.00299

Ejemplares similares

The clinical and genetic characteristics of permanent neonatal diabetes (PNDM) in the state of Qatar
por: Al‐Khawaga, Sara, et al.
Publicado: (2019)

Somatostatin analogues for the treatment of hyperinsulinaemic hypoglycaemia
por: Haris, Basma, et al.
Publicado: (2020)

A Systematic Review of Childhood Diabetes Research in the Middle East Region
por: Saraswathi, Saras, et al.
Publicado: (2019)

Homozygous Insulin Promotor Gene Mutation Causing Permanent Neonatal Diabetes Mellitus and Childhood Onset Autoantibody Negative Diabetes in the Same Family
por: Haris, Basma, et al.
Publicado: (2022)

Epidemiology, genetic landscape and classification of childhood diabetes mellitus in the State of Qatar
por: Haris, Basma, et al.
Publicado: (2021)

Enhanced differentiation of human pluripotent stem cells into pancreatic progenitors co-expressing PDX1 and NKX6.1
por: Memon, Bushra, et al.
Publicado: (2018)

Correction to: Enhanced differentiation of human pluripotent stem cells into pancreatic progenitors co-expressing PDX1 and NKX6.1
por: Memon, Bushra, et al.
Publicado: (2018)

Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients
por: Al-Khawaga, Sara, et al.
Publicado: (2020)

PGAP3 Associated with Hyperphosphatasia with Mental Retardation Plays a Novel Role in Brain Morphogenesis and Neuronal Wiring at Early Development
por: Da’as, Sahar I., et al.
Publicado: (2020)

Butyric acid increases transepithelial transport of ferulic acid through upregulation of the monocarboxylate transporters SLC16A1 (MCT1) and SLC16A3 (MCT4)
por: Ziegler, Kerstin, et al.
Publicado: (2016)

Deafness and loss of cochlear hair cells in the absence of thyroid hormone transporters Slc16a2 (Mct8) and Slc16a10 (Mct10)
por: Sharlin, David S., et al.
Publicado: (2018)

Clinical features, epidemiology, autoantibody status, HLA haplotypes and genetic mechanisms of type 1 diabetes mellitus among children in Qatar
por: Haris, Basma, et al.
Publicado: (2021)

Indole Derivatives as New Structural Class of Potent and Antiproliferative Inhibitors of Monocarboxylate Transporter 1 (MCT1; SLC16A1)
por: Puri, Sachin, et al.
Publicado: (2022)

Inhibition of Hypothalamic MCT4 and MCT1–MCT4 Expressions Affects Food Intake and Alters Orexigenic and Anorexigenic Neuropeptide Expressions
por: Elizondo-Vega, Roberto, et al.
Publicado: (2019)

Optimisation of immunofluorescence methods to determine MCT1 and MCT4 expression in circulating tumour cells
por: Kershaw, Stephen, et al.
Publicado: (2015)

Functional heterogeneity of MCT1 and MCT4 in metabolic reprogramming affects osteosarcoma growth and metastasis
por: Sheng, Gaohong, et al.
Publicado: (2023)

Monocarboxylate Transporters 1–4 in NSCLC: MCT1 Is an Independent Prognostic Marker for Survival
por: Eilertsen, Marte, et al.
Publicado: (2014)

Prognostic Value of SLC16A3(MCT4) in Lung Adenocarcinoma and Its Clinical Significance
por: Xue, Lei, et al.
Publicado: (2021)

Monocarboxylate Transporter 1 (MCT1) in Liver Pathology
por: Droździk, Marek, et al.
Publicado: (2020)

Role of Human Monocarboxylate Transporter 1 (hMCT1) and 4 (hMCT4) in Tumor Cells and the Tumor Microenvironment
por: Liu, Tian, et al.
Publicado: (2023)

Haploinsufficiency of the FOXA2 associated with a complex clinical phenotype
por: Mohammed, Idris, et al.
Publicado: (2020)

Tissue expression of lactate transporters (MCT1 and MCT4) and prognosis of malignant pleural mesothelioma (brief report)
por: Dell’Anno, Irene, et al.
Publicado: (2020)

A Novel Homozygous MC2R Variant Leading to Type-1 Familial Glucocorticoid Deficiency
por: Mohammed, Idris, et al.
Publicado: (2022)

MCT8 deficiency in a patient with a novel frameshift variant in the SLC16A2 gene
por: Wakabayashi, Kei, et al.
Publicado: (2021)

Critical Velocity, Maximal Lactate Steady State, and Muscle MCT1 and MCT4 after Exhaustive Running in Mice
por: Orsi, Juan B., et al.
Publicado: (2023)

Mammalian monocarboxylate transporter 7 (MCT7/Slc16a6) is a novel facilitative taurine transporter
por: Higuchi, Kei, et al.
Publicado: (2022)

Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1α, CAIX, LDH-5, GLUT-1, MCT1 and MCT4
por: Rademakers, Saskia E, et al.
Publicado: (2011)

Natural Autoimmunity to the Thyroid Hormone Monocarboxylate Transporters MCT8 and MCT10
por: Porst, Theresa, et al.
Publicado: (2021)

Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer
por: Curry, Joseph M., et al.
Publicado: (2013)

MCT1 and MCT4 Expression and Lactate Flux Activity Increase During White and Brown Adipogenesis and Impact Adipocyte Metabolism
por: Petersen, Charlotte, et al.
Publicado: (2017)

Dual Inhibition of the Lactate Transporters MCT1 and MCT4 Is Synthetic Lethal with Metformin due to NAD+ Depletion in Cancer Cells
por: Benjamin, Don, et al.
Publicado: (2018)

Monocarboxylate Transporter 1 (MCT1) Mediates Succinate Export in the Retina
por: Bisbach, Celia M., et al.
Publicado: (2022)

The Expression of Glut-1, CAIX, and MCT4 in Mucinous Carcinoma
por: Kim, Sewha, et al.
Publicado: (2013)

MCT1 regulates aggressive and metabolic phenotypes in bladder cancer
por: Zhang, Guiming, et al.
Publicado: (2018)

Three novel mutations of the MCT8 (SLC16A2) gene: individual and temporal variations of endocrinological and radiological features
por: Ono, Erina, et al.
Publicado: (2016)

Histological characterization of orphan transporter MCT14 (SLC16A14) shows abundant expression in mouse CNS and kidney
por: Roshanbin, Sahar, et al.
Publicado: (2016)

Monocarboxylate Transporter 13 (MCT13/SLC16A13) Functions as a Novel Plasma Membrane Oligopeptide Transporter
por: Higuchi, Kei, et al.
Publicado: (2023)

Monocarboxylate Transporter 1 (MCT1) is an independent prognostic biomarker in endometrial cancer
por: Latif, Ayşe, et al.
Publicado: (2017)

High expression of monocarboxylate transporter 4 (MCT 4), but not MCT 1, predicts poor prognosis in patients with non-small cell lung cancer
por: Tong, Ying-Hui, et al.
Publicado: (2021)

Presenting symptoms and time to diagnosis for Pediatric Central Nervous System Tumors in Qatar: a report from Pediatric Neuro-Oncology Service in Qatar
por: Maaz, Ata U. R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d5u52v70lij35vc3pco0j0a0ju